Loading…
Lobbying Spend
—
Filings
50
Firms Hired
1
Active Period
2005–2018
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
SUPPORT for Patients and Communities Act
2018 · fourth_quarter · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6
SUPPORT for Patients and Communities Act
2018 · third_quarter · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6
SUPPORT for Patients and Communities Act
2018 · second_quarter · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Opioid legislation, including H.R. 6, the SUPPORT for Patients and Communities Act and Senate measures related to prescription drug abuse
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6
A bill to establish a statute of limitations for certain actions of the Securities and Exchange Commission, and for other purposes.
2018 · first_quarter · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Client expense: — · Firm income: $30,000
Matched citations: S. 1960
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
2018 · first_quarter · Firm: NOSSAMAN LLP
Repeal of LIFO (Last in, First Out), H.R. 1 Tax Cuts and Jobs Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
A bill to establish a statute of limitations for certain actions of the Securities and Exchange Commission, and for other purposes.
2018 · first_quarter · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and implementation of the Drug Quality Security Act. S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Client expense: — · Firm income: $30,000
Matched citations: S. 1960
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
2017 · fourth_quarter · Firm: NOSSAMAN LLP
Repeal of LIFO (Last in, First Out), H.R. 1 Tax Cuts and Jobs Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
A bill to establish a statute of limitations for certain actions of the Securities and Exchange Commission, and for other purposes.
2017 · fourth_quarter · Firm: NOSSAMAN LLP
Medicare Prompt Pay Discount Exclusion, legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Proposals to exclude cancer drugs from sequestration cuts. Medicare Program Part B Drug Payment Model. Legislation to prevent and reduce prescription drug abuse, Pharmaceutical compounding and Implementation of the Drug Quality Security Act, S. 1960- A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patients Access and Effective Drug Enforcement Act of 2016
Client expense: — · Firm income: $30,000
Matched citations: S. 1960
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
2016 · fourth_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: HR471
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · fourth_quarter · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: H.R.696
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · fourth_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 696
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
2016 · fourth_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S483
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · fourth_quarter · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S.506
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · fourth_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S. 506
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
2016 · third_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: HR471
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 696
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: H.R.696
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
2016 · third_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S483
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S.506
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S. 506
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
2016 · second_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: HR471
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · second_quarter · Firm: NOSSAMAN LLP
(H.R.696/S.506) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP) generally (in the context of deficit reduction); Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: H.R.696
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · second_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 696
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
2016 · second_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S483
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · second_quarter · Firm: NOSSAMAN LLP
(H.R. 696/S. 506) Medicare Prompt Pay Discount Exclusion,legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Legislation to exclude cancer drugs from sequestration cuts. HR471/S483 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Medicare Program Part B Drug Payment Model.
Client expense: — · Firm income: $30,000
Matched citations: S. 506
Source: Senate LDA